At September 30, 2025, Edesa had cash and cash equivalents of $10.8 million and working capital of $10.4 million. Subsequent to the fiscal year end, the company received $3.4 million in net proceeds, ...

Zealand Pharma may be gearing up for a high-stakes year of obesity readouts, but the Danish biopharma thinks the brain could hold the key to the company’s long-term success. | Zealand Pharma may be ...

A 2025 report from a bipartisan, congressionally chartered commission warns that China is closing in on a win, and the United ...

A raging bull market for biotech stocks and a good story have transformed an ineffective weight loss drug into a Wall Street ...

After nearly 30 years of planning, the University of South Dakota Discovery District now provides lab and office space to ...

I put an Interior Define sofa to the test to see how it performed in the face of the ultimate judge: my cat. Our editors and experts handpick every product we feature. We may earn a commission from ...